Kolinpharma® obtains 3 patents in European Union with validation in 12 new countries beyond Italy. -28/5/202028 May 2020
Kolinpharma® expands on the European market and obtains the patent for 3 products with validation in 12 new countries.
By obtaining 3 patents for Xinepa® (formulation patent and technological process patent) and Almetax® (formulation patent), as well as validation for the official entry into the markets of 12 new European countries beyond Italy, the foundations were laid for expansion in Europe. We continue our growth path. This is a great milestone that sees the company move forward in a reference market characterized by large volumes and constant growth.
Are you a supplier?
Here's what CPhI Online can do for you
- Generate quality leads for your business
- Stay visible for 365 days of the year
- Receive product inquiries and respond to meeting requests directly
- Improve company online presence through Search Engine Optimisation